Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003675	li-hb	— (—)	42	45	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Migraine

10.89

7.40

1.1

1.0

—

Nerve, nerve root and plexus disorders

4.80

6.09

1.2

1.0

—

Other headache syndromes

11.07

5.77

1.0

—

Shoulder lesions

7.79

5.54

1.2

1.0

—

Other shoulder lesions

+∞

5.21

1.4

0.0

—

Implicit bacterial Sepsis, including avohilmo

13.30

4.86

1.4

1.0

—

Lumbar disc prolapse

6.35

4.81

1.2

1.0

—

Episodal and paroxysmal disorders

5.46

4.60

1.1

1.0

—

Cervical disc disorders

14.00

4.57

1.1

1.0

—

Rotator cuff syndrome

8.85

4.38

1.2

1.0

—

Other intervertebral disc disorders

5.17

4.31

1.2

1.0

—

Implicit viral Sepsis, including avohilmo

11.64

4.26

1.4

1.0

—

Implicit Sepsis

5.79

4.20

1.3

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

5.55

3.96

1.2

1.1

—

Bacterial Sepsis

9.64

3.79

1.4

1.0

—

Implicit Sepsis, including avohilmo

4.91

3.72

1.3

1.0

—

Sciatica+with lumbago

7.08

3.71

1.4

1.0

—

Non-invasive ventilation

8.63

3.64

1.1

1.0

—

Other soft tissue disorders, not elsewhere classified

4.55

3.62

1.3

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

5.52

3.60

1.0

—

Other neurological diseases

5.81

3.57

1.0

1.1

—

Soft tissue disorders

4.16

3.53

1.1

1.0

—

Symptoms and signs involving the urinary system

5.03

3.53

1.3

1.0

—

Other/unspecified dorsalgia

9.88

3.47

1.3

1.0

—

Metabolic disorders

4.23

3.46

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

4.55

3.42

1.0

—

Pure hypercholesterolaemia

5.71

3.39

1.0

—

Opioids

3.53

3.34

1.1

1.0

—

Hard cardiovascular diseases

4.92

3.31

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

4.23

3.30

1.3

1.0

—

Abnormal findings on examination of blood, without diagnosis

9.05

3.28

1.2

1.0

—

Dorsalgia

3.44

3.26

1.2

1.0

—

Migraine without aura

8.57

3.26

1.3

1.0

—

Spondylosis

9.37

3.23

1.2

1.0

—

Sub-endpoint used in defining T1D endpoints

8.43

3.22

1.2

1.0

—

Codeine

3.70

3.22

1.2

1.0

—

Injuries to the wrist and hand

3.19

3.17

1.0

1.1

—

Pain in limb

4.54

3.17

1.3

1.0

—

Intestinal infectious diseases

3.33

3.08

1.2

1.0

—

Unspecified haematuria

8.14

3.05

1.2

1.0

—

Keratitis

5.00

3.05

1.0

1.1

—

Other diseases of anus and rectum

9.96

2.97

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

6.67

2.86

1.0

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

5.38

2.86

1.0

1.1

—

Migraine with aura

6.66

2.86

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.61

2.86

1.1

1.0

—

Striking against or struck by other objects

5.38

2.86

1.0

1.1

—

Carpal tunnel syndrome

5.51

2.84

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

5.83

2.80

1.1

1.0

—

Viral and other specified intestinal infections, including avohilmo

5.18

2.77

1.3

1.0

—

Neurological diseases

4.52

2.75

1.1

1.0

—

Migraine without aura and triptan purchases

8.34

2.75

1.4

1.0

—

Type 1 diabetes

5.99

2.69

1.2

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

4.93

2.69

1.4

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3.37

2.68

1.3

1.0

—

Depression or dysthymia

4.85

2.67

1.0

—

Ischaemic Stroke, excluding all haemorrhages

6.31

2.62

1.0

—

Stroke, excluding SAH

6.18

2.58

1.0

—

Stroke, including SAH

6.15

2.57

1.0

—

Injuries to the neck

7.14

2.55

1.4

1.1

—

Pain in throat and chest

2.96

2.55

1.1

1.0

—

Type 1 diabetes, wide definition, subgroup 1

7.14

2.54

1.0

—

Type 1 diabetes, wide definition

7.14

2.54

1.0

—

Sleep apnoea

3.50

2.54

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.30

2.54

1.3

1.0

—

Cerebrovascular diseases

4.85

2.51

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.36

2.46

1.1

1.0

—

STROKE

5.77

2.45

1.0

—

Complications of medical and surgical care

3.78

2.41

1.1

1.0

—

Diseases of salivary glands

5.00

2.40

1.2

1.0

—

Codeine or tramadol medication

2.71

2.35

1.2

1.0

—

Other viral diseases, including avohilmo

4.08

2.33

1.1

1.0

—

Viral and other specified intestinal infections

6.10

2.33

1.0

—

Other viral diseases

4.60

2.26

1.2

1.0

—

Embedded and impacted teeth

4.06

2.26

1.4

1.0

—

Hypertension, essential

3.39

2.22

1.1

1.0

—

Functional dyspepsia

5.56

2.21

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

5.56

2.21

1.4

1.0

—

Explicit Sepsis

5.69

2.21

1.6

1.0

—

Explicit Sepsis, including avohilmo

5.66

2.20

1.6

1.0

—

Transport accidents

3.88

2.19

1.3

1.0

—

Type 2 diabetes, wide definition

3.60

2.18

1.1

1.0

—

Other dorsopathies, not elsewhere classified

2.86

2.13

1.1

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

2.84

2.12

1.1

—

Disorders of synovium and tendon

4.24

2.08

1.0

—

Covid-19 confirmed case

4.99

2.07

1.2

1.0

—

Necrosis of pulp, including avohilmo

3.16

2.06

1.1

1.0

—

Dorsopathies

2.78

2.04

1.1

1.0

—

Spondylopathies

3.76

2.01

1.4

1.0

—

Sleep disorders (combined)

2.73

2.00

1.1

1.0

—

Diverticular disease of intestine

5.19

1.94

1.2

1.0

—

Spontaneous abortion

4.02

1.92

1.0

1.2

—

Abnormalities of heart beat

4.41

1.89

1.6

1.0

—

Low back pain

3.00

1.86

1.4

1.0

—

Diseases of arteries, arterioles and capillaries

4.58

1.86

1.2

1.0

—

Injuries to the thorax

3.53

1.83

1.0

1.1

—

Care involving use of rehabilitation procedures

3.15

1.83

1.1

1.0

—

Type of accident

4.17

1.82

1.0

1.1

—

Hypertension

3.01

1.81

1.1

1.0

—

Asthma, unspecified (mode)

3.61

1.78

1.2

1.0

—

Asthma, unspecified (mode), excluding more controls

3.58

1.77

1.2

1.0

—

Recurrent or chronic depression

4.33

1.77

1.0

—

Acute sinusitis

3.03

1.77

1.4

1.0

—

Certain infectious and parasitic diseases

2.78

1.75

1.1

1.0

—

Dizziness and giddiness

3.02

1.73

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.67

1.72

1.1

1.0

—

Insulin, fast-acting

3.84

1.71

1.0

—

Unspecified fall

3.27

1.71

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.64

1.69

1.1

1.0

—

Hypertensive diseases

2.82

1.69

1.1

1.0

—

Complications of procedures, not elsewhere classified

2.68

1.69

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.57

1.68

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases

2.32

1.66

1.1

—

Cardiac arrhythmias

2.99

1.66

1.1

1.0

—

Acute appendicitis, no complications

2.78

1.63

1.3

1.0

—

Dental pulpitis, including avohilmo

2.35

1.63

1.0

1.1

—

Other arrhythmias

3.20

1.61

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3.57

1.61

1.0

1.1

—

Appendectomy

2.54

1.61

1.3

1.0

—

Insulin, fast-acting or short human

3.57

1.61

1.0

1.1

—

Erysipelas

3.59

1.59

1.2

1.0

—

Intracranial trauma

3.75

1.58

1.4

1.0

—

All chronic kidney diseases

3.62

1.58

1.4

1.0

—

L04AX Other immunosuppressants

3.00

1.58

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.96

1.55

1.3

1.1

—

Injuries to the knee and lower leg

2.24

1.55

1.3

1.0

—

Excessive, frequent and irregular menstruation

3.81

1.53

1.2

1.3

—

Examination and observation for other reasons

2.82

1.53

1.4

1.0

—

Lower back pain or/and sciatica

2.28

1.53

1.3

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.86

1.49

1.2

1.0

—

Other bacterial diseases

2.48

1.48

1.3

1.0

—

Hypertensive diseases (excluding secondary)

2.71

1.48

1.1

1.0

—

Fracture of lower leg, including ankle

2.80

1.47

1.0

—

Dermatitis

2.79

1.46

1.0

—

Injuries to the ankle and foot

2.40

1.46

1.2

1.0

—

All kidney diseases

2.31

1.46

1.3

1.0

—

Visual disturbances

3.13

1.44

1.0

1.1

—

Visual disturbances and blindness

3.12

1.43

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

2.70

1.42

1.5

1.0

—

Codes for special purposes

2.70

1.42

1.5

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.45

1.40

1.1

1.0

—

Triptan medication for migraine, min. 3 purchases

2.49

1.39

1.4

1.0

—

Injuries to the head

2.17

1.38

1.2

1.0

—

Cystitis

2.64

1.36

1.1

1.0

—

Fall on same level involving ice and snow

2.61

1.36

1.0

—

Second line medication for Crohn's disease

2.61

1.36

1.0

—

Injuries to the hip and thigh

2.99

1.36

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.22

1.34

1.1

1.0

—

Other joint disorders

2.27

1.33

1.1

—

Any mental disorder

2.28

1.32

1.1

1.0

—

Cardiovascular diseases

2.50

1.32

1.1

1.0

—

Antihypertensive medication - note that there are other indications

2.46

1.31

1.1

1.0

—

Other disorders of urethra and urinary system

2.61

1.31

1.3

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.14

1.30

1.0

1.1

—

Insulin, intermediate and long-acting

2.84

1.30

1.0

—

Impacted teeth

2.86

1.30

1.6

1.0

—

Excessive earwax

2.83

1.29

1.0

1.1

—

Other and unspecified dermatitis

2.78

1.28

1.0

1.1

—

Cholelithiasis

2.56

1.28

1.2

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.33

1.27

1.4

1.0

—

Reimbursement for rheumatic diseases

2.76

1.27

1.0

1.1

—

Diseases of appendix

2.31

1.27

1.3

1.0

—

Insulin medication

2.49

1.27

1.2

1.0

—

Other antidepressants

2.22

1.27

1.1

1.0

—

Other and unspecified tonsillitis

2.77

1.25

1.4

1.0

—

Cholelithiasis, broad definition with cholecystitis

2.49

1.24

1.2

1.0

—

Other specific joint derangements/joint disorders

2.26

1.23

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.14

1.20

1.1

1.0

—

2.61

1.20

1.2

1.0

—

Cholecystectomy

2.65

1.20

1.2

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.15

1.19

1.1

—

Gastro-oesophageal reflux disease

2.63

1.19

1.0

1.1

—

Other disorders of ear

2.51

1.16

1.3

1.1

—

2.11

1.14

1.1

1.0

—

Sleep apnoea, including avohilmo

2.10

1.14

1.1

1.0

—

Benign neoplasms

2.09

1.14

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.36

1.12

1.0

—

Conjunctivitis

2.01

1.11

1.1

—

Autoimmune diseases

1.99

1.11

1.1

—

Renal tubulo-interstitial diseases

2.14

1.05

1.4

1.0

—

Acute appendicitis

2.09

1.04

1.3

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.06

1.02

1.1

—

Diabetes mellitus

1.92

1.01

1.1

1.0

—

Appendicitis, broad definition

2.02

1.00

1.3

1.0

—

Other diseases of urinary system

2.07

1.00

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

1.88

0.98

1.1

1.0

—

Bronchitis

1.93

0.98

1.3

1.0

—

Polyarthropathies

2.41

0.97

1.0

—

Tramadol

2.40

0.97

1.5

1.0

—

Other diseases of intestines

1.92

0.95

1.1

—

Abdominal and pelvic pain

2.11

0.94

1.1

1.0

—

Psychiatric diseases

2.11

0.94

1.1

1.0

—

Persons encountering health services for specific procedures and health care

1.90

0.94

1.1

—

Asthma (mode)

2.25

0.93

1.2

1.0

—

Asthma

2.21

0.92

1.2

1.0

—

Asthma, excluding more controls

2.20

0.91

1.2

1.0

—

Inflammatory diseases of female pelvic organs

2.16

0.91

1.3

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.94

0.90

1.1

—

ILD medications: immunosuppressive drugs

2.09

0.89

1.0

—

Disorders of conjunctiva

1.94

0.89

1.1

—

Acute upper respiratory infections

1.92

0.89

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.89

0.88

1.3

1.0

—

Other heart diseases, wide

1.86

0.87

1.1

1.0

—

Allergic conjunctivitis

1.99

0.86

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

2.00

0.86

1.0

—

Diseases of the respiratory system

0.00

0.84

0.0

1.0

—

Type 2 diabetes

1.78

0.83

1.1

1.0

—

Diseases of oesophagus, stomach and duodenum

1.75

0.81

1.0

—

Other bacterial diseases, including avohilmo

1.72

0.80

1.4

1.0

—

Percutaneous Coronary Intervention

2.34

0.79

1.2

1.0

—

Coronary revascularization (ANGIO or CABG)

2.33

0.79

1.2

1.0

—

Emergency coronary revascularization (for ACS)

2.32

0.78

1.2

1.0

—

Major coronary heart disease event

2.30

0.78

1.2

1.0

—

Oral corticosteroids

1.76

0.78

1.1

—

Other obstetric conditions, not elsewhere classified

2.25

0.77

1.2

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.25

0.77

1.2

1.1

—

Heart failure, not strict

2.24

0.77

1.6

1.0

—

Other maternal disorders predominantly related to pregnancy

2.23

0.77

1.0

1.1

—

Disorders of choroid and retina

2.19

0.76

1.2

1.0

—

Used for control exclusion in common control thyroid runs

1.68

0.75

1.1

—

Asthma-related infections

2.12

0.75

1.2

1.0

—

Asthma, hospital admission 2, infections

2.12

0.75

1.2

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.90

0.75

1.1

1.0

—

Triptan medication for migraine, single purchase ok

1.90

0.75

1.1

1.0

—

Ischemic heart diseases

2.12

0.75

1.2

1.0

—

Mood disorders, excluding more controls

1.87

0.74

1.0

—

Injuries to the shoulder and upper arm

1.86

0.74

1.3

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.82

0.73

1.4

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.80

0.73

1.1

1.0

—

Hernia

1.79

0.72

1.0

—

Asthma (only as main-diagnosis)

2.00

0.71

1.2

1.0

—

Pregnancy with abortive outcome

2.00

0.71

1.2

—

Asthma (only as main-diagnosis), excluding more controls

1.97

0.71

1.2

1.0

—

Abnormalities of breathing

1.74

0.70

1.1

1.0

—

Exposure to other specified factors

1.72

0.70

1.0

1.1

—

Pneumonia, organism unspecified

1.71

0.70

1.4

1.0

—

Erysipelas, including avohilmo

1.85

0.68

1.2

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

1.67

0.67

1.1

1.0

—

COPD/asthma related infections

1.67

0.67

1.1

1.0

—

COPD/asthma/ILD related infections

1.67

0.67

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.77

0.65

1.0

1.1

—

Infections of the skin and subcutaneous tissue

1.76

0.65

1.0

—

Persons encountering health services in circumstances related to reproduction

1.76

0.64

1.0

—

Diabetes medication

1.67

0.63

1.1

1.0

—

Depression

1.67

0.63

1.0

1.1

—

Diabetes, varying definitions

1.66

0.63

1.1

1.0

—

Mood [affective] disorders

1.60

0.61

1.0

1.1

—

Mood disorders

1.60

0.61

1.0

1.1

—

Exposure to unspecified factor

1.60

0.61

1.0

1.1

—

Nonsuppurative otitis media, including avohilmo

0.00

0.61

0.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.53

0.59

1.1

—

Anxiety disorders, excluding more controls

1.74

0.58

1.2

1.0

—

Parasetamol

1.68

0.57

1.2

1.0

—

ILD medications

1.56

0.57

1.1

—

Chronic lower respiratory diseases

1.48

0.54

1.1

—

Asthma, hospital admissions , main diagnosis only

1.53

0.52

1.2

1.1

—

Autoimmune diseases related-to ILD

1.52

0.52

1.3

1.0

—

Selective serotonin reuptake inhibitors

1.58

0.50

1.0

—

Arthropathies

1.54

0.49

1.1

—

Use of hypnotics and sedatives

1.54

0.49

1.3

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.53

0.48

1.1

1.0

—

Asthma/COPD (KELA code 203)

1.46

0.47

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.46

0.47

1.4

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.73

0.45

1.2

1.0

—

Influenza and pneumonia

1.49

0.44

1.4

1.0

—

Diseases of the ear and mastoid process

1.43

0.43

1.0

—

Diseases of the eye and adnexa

1.57

0.42

1.2

1.1

—

Other external causes of accidental injury

1.57

0.42

1.2

1.0

—

Accidents

1.57

0.42

1.2

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.58

0.42

1.2

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.56

0.42

1.6

1.0

—

Inflammatory bowel disease treatment related agents

1.39

0.42

1.1

—

Asthma, including avohilmo

1.38

0.42

1.1

—

Special screening examination for infectious and parasitic diseases

0.00

0.41

0.0

1.0

—

Any death

0.00

0.41

0.0

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.48

0.40

1.2

1.0

—

Alcohol use disorder, ICD-based

0.00

0.40

0.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

0.00

0.40

0.0

1.1

—

Polycystic ovarian syndrome, consortium definition

1.43

0.39

1.0

1.2

—

Chronic diseases of tonsils and adenoids

1.51

0.37

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.46

0.36

1.3

1.0

—

Gingivitis and periodontal diseases

1.41

0.35

1.2

1.1

—

Sleep disorders

1.33

0.34

1.0

—

Chronic periodontitis, including avohilmo

1.32

0.33

1.0

—

Periodontitis

1.32

0.33

1.0

—

Insomnia

1.30

0.33

1.0

—

Diseases of the skin and subcutaneous tissue

1.40

0.33

1.1

1.0

—

Falls/tendency to fall

1.40

0.32

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

1.34

0.31

1.4

1.0

—

All pneumoniae

1.34

0.31

1.4

1.0

—

First line medication for Crohn's disease

1.34

0.29

1.1

—

Any reimbursement code in KELA

1.39

0.24

1.2

1.1

—

1.39

0.24

1.6

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.39

0.24

1.6

1.0

—

Artrosis, including avohilmo

1.37

0.24

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.30

0.23

1.0

1.1

—

Factors influencing health status and contact with health services

0.00

0.22

0.0

1.0

—

Injury, poisoning and certain other consequences of external causes

0.00

0.22

0.0

1.0

—

Other (not insulin) diabetes medications

1.22

0.22

1.2

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast, HER-positive

0.00

0.22

0.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.20

0.22

1.0

—

Degeneration of macula and posterior pole

0.00

0.22

0.0

1.0

—

COPD

0.00

0.21

0.0

1.0

—

Malignant neoplasm of digestive organs

0.00

0.21

0.0

1.0

—

Malignant neoplasm of digestive organs, including Hilmo

0.00

0.21

0.0

1.0

—

Liquid cancers, including Hilmo

0.00

0.21

0.0

1.0

—

COPD, hospital admissions

0.00

0.21

0.0

1.0

—

COPD, early/later onset

0.00

0.21

0.0

1.0

—

Gestational [pregnancy-induced] hypertension

0.00

0.21

0.0

1.1

—

Sulfasalazine

0.00

0.21

0.0

1.0

—

Retinal detachments and breaks

0.00

0.21

0.0

1.0

—

Other benign neoplasms of skin

0.00

0.21

0.0

1.1

—

Other and unspecified iron deficiency

0.00

0.21

0.0

1.1

—

In situ neoplasms

0.00

0.21

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.00

0.21

0.0

1.1

—

Malignant neoplasm of breast

0.00

0.21

0.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

0.21

0.0

1.1

—

Malignant neoplasm of breast, including Hilmo

0.00

0.21

0.0

1.1

—

Lyme disease

0.00

0.21

0.0

1.1

—

Lyme disease, including avohilmo

0.00

0.21

0.0

1.1

—

Spirochaetal infections, other/unspecified, including avohilmo

0.00

0.21

0.0

1.1

—

Other spirochaetal diseases

0.00

0.21

0.0

1.1

—

Other spirochaetal diseases, including avohilmo

0.00

0.21

0.0

1.1

—

Abrasion of teeth

0.00

0.21

0.0

1.1

—

Senile cataract

0.00

0.20

0.0

1.0

—

Heart failure,strict

0.00

0.20

0.0

1.0

—

All-cause Heart Failure

0.00

0.20

0.0

1.0

—

Heart failure, strict

0.00

0.20

0.0

1.0

—

Other medical care

0.00

0.20

0.0

1.0

—

Neoplasms

1.21

0.20

1.2

1.1

—

Other diseases of upper respiratory tract

1.20

0.20

1.0

—

Neurotic, stress-related and somatoform disorders

1.21

0.20

1.2

1.0

—

Anxiety disorders

1.21

0.20

1.2

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

1.17

0.19

1.2

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.16

0.18

1.0

—

Any gastric operation

1.19

0.10

1.2

1.0

—

GASTRO-related operations

1.19

0.10

1.2

1.0

—

Endocrine, nutritional and metabolic diseases

1.15

0.10

1.2

1.1

—

Finngen Rheumatological endpoints

1.13

0.09

1.0

1.1

—

Dermatitis and eczema

1.04

0.08

1.0

1.1

—

Fall on same level

1.10

0.08

1.3

1.0

—

COPD, hospital admission 2, with asthma infections

0.00

0.0

1.0

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

Nontoxic goitre/thyroid nodule

0.00

0.0

1.1

—

0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

0.0

1.0

—

Early onset COPD

0.00

0.0

1.0

—

Non-selective monoamine reuptake inhibitors

0.00

0.0

1.0

—

Persons encountering health services in other circumstances, wide

0.96

0.00

1.0

—

Medicines for HER+ breast cancer

0.00

0.0

1.1

—

Cardiodefibrillation

0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri

0.00

0.0

1.0

—

Sulfonylureas

0.00

0.0

1.0

—

Unspecified lump in breast

0.00

0.0

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

0.00

0.0

1.0

—

Thyrotoxicosis

0.00

0.0

1.1

—

Foreign body on external eye

0.00

0.0

1.0

—

Covid-19 suspected case

0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Eating disorder

0.00

-0.00

0.0

1.2

—

Primary open-angle glaucoma, strict

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis, other and/or unspecified

0.00

-0.00

0.0

1.0

—

Primary open-angle glaucoma

0.00

-0.00

0.0

1.0

—

Liquid cancers

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER-negative

0.00

-0.00

0.0

1.0

—

Colonic or urogenital fistula

0.00

-0.00

0.0

1.1

—

Paralytic ileus and intestinal obstruction

0.00

-0.00

0.0

1.0

—

Eating disorders

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

-0.00

0.0

1.0

—

Actinic keratosis

0.00

-0.00

0.0

1.0

—

Coxarthrosis, primary, with hip surgery

0.00

-0.00

0.0

1.0

—

Non-rheumatic valve diseases

0.00

-0.00

0.0

1.0

—

Phobic anxiety disorders

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.0

—

Other chronic obstructive pulmonary disease

0.00

-0.00

0.0

1.0

—

Persistent mood disorders

0.00

-0.00

0.0

1.2

—

Presence of other devices

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.0

—

Irritable bowel syndrome

0.00

-0.00

0.0

1.0

—

Other diseases of the digestive system

0.00

-0.00

0.0

1.0

—

Stomatitis and related lesions

0.00

-0.00

0.0

1.1

—

Other bacterial intestinal infections, including avohilmo

0.00

-0.00

0.0

1.0

—

N06DA Anticholinesterases

0.00

-0.00

0.0

1.0

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.2

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.0

—

Benzodiazepine use

0.99

-0.00

1.4

1.0

—

Benign neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.1

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.1

—

Intestinal stricture

0.00

-0.00

0.0

1.0

—

Fissure and fistula of anal and rectal regions

0.00

-0.00

0.0

1.0

—

Congenital malformations of genital organs

0.00

-0.00

0.0

1.2

—

Abnormalities of forces of labour

0.00

-0.00

0.0

1.2

—

GI-bleeding

0.00

-0.00

0.0

1.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

-0.00

0.0

1.2

—

Degenerative diseases of the nervous system

0.00

-0.00

0.0

1.0

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Colorectal cancer

0.00

-0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

1.1

—

COPD related to multimorbidity

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.2

—

Other disorders of amniotic fluid and membranes

0.00

-0.00

0.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Acute appendicitis, with complications

0.00

-0.00

0.0

1.0

—

Use of anticholinesterases

0.00

-0.00

0.0

1.0

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

1.0

—

Colorectal cancer, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

-0.00

0.0

1.0

—

Nasal polyp

0.00

-0.00

0.0

1.0

—

Osteoporosis

0.00

-0.00

0.0

1.0

—

Benign thyroid growths and nodules

0.00

-0.00

0.0

1.0

—

Heart failure and bmi 25plus

0.00

-0.00

0.0

1.0

—

Disorders of parathyroid gland

0.00

-0.00

0.0

1.0

—

Alcohol dependence

0.00

-0.00

0.0

1.0

—

Valvular heart disease excluding rheumatic fever

0.00

-0.00

0.0

1.0

—

Non-ischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Panic disorder

0.00

-0.00

0.0

1.0

—

Chronic apical periodontitis

0.96

-0.00

1.0

1.1

—

0.00

-0.00

0.0

1.0

—

Nontoxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Heart failure and coronary heart disease

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS